Michael Marvin, MD
Transplant Surgery · Danville, PANPI 1265455406
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 53.4% of the total. Among transplant surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 99 payments — averaging $1448.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$77K
- Veloxis Pharmaceuticals, Inc.$32K
- E.r. Squibb & Sons, L.L.C.$23K
- Sanofi$11K
- Boston Scientific$150
- Covidien LP$102
- plus $177 from 3 others
What the payments were for
- Consulting fees$32,43323%
- Speaking & faculty fees$84,38359%
- Travel & lodging$23,02416%
- Food & beverage$3,5132%
- Education$560%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 32 | $76,519 |
| Veloxis Pharmaceuticals, Inc. | 41 | $32,107 |
| E.r. Squibb & Sons, L.L.C. | 12 | $22,908 |
| Sanofi | 9 | $11,446 |
| Boston Scientific | 1 | $150 |
| Covidien LP | 1 | $102 |
| Medtronic | 1 | $80 |
| Johnson & Johnson | 1 | $69 |
| Kamada Ltd. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THYMOGLOBULIN$83,664
- Envarsus$43,046
- NULOJIX$22,672
- NO PRODUCT DISCUSSED$3,759
- THERASPHERE$150
- Valleylab$102
How this compares
$143,409 in reported general payments places this provider in the 95th percentile of 41 transplant surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valganciclovir Hcl | 23 | $5,840 |
| Envarsus XrTacrolimus | 14 | $5,168 |
| Mycophenolate Mofetil | 16 | $1,056 |
| Omeprazole | 48 | $402 |
| Carvedilol | 24 | $186 |
| Prednisone | 17 | $179 |
| Atorvastatin Calcium | 12 | $74 |
| Amlodipine Besylate | 19 | $62 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $60 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Danville
- Anil KotruDanville$8K
- Clifford AkatehDanville$2K
- Adam BodzinPhiladelphia$75K
- Peter AbtPhiladelphia$10K
- Ira FoxPittsburgh$7K
- Berjesh ShardaIndiana$6K
- Muhammad SaeedPhiladelphia$4K
- Kenneth AndreoniPhiladelphia$4K
- Armando Ganoza SalasPittsburgh$3K
- Ignazio MarinoPhiladelphia$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.